Bill & Melinda Gates Foundation

Likarda is a biotechnology company focused on developing innovative cell therapies and delivery technologies. Utilizing its patented Core-Shell Spherification® platform, Likarda specializes in cell encapsulation within biocompatible hydrogels, such as Hyaluronic Acid and PEG, which allows for customized delivery solutions tailored to the unique specifications of various cell therapies. The company's approach enables the creation of microcapsules that can provide injectable treatments with enhanced localization and efficacy or offer immunoprotective barriers for long-term cell transplants. Likarda is actively working on therapies for diabetes and osteoarthritis, including the delivery of islet-like cells for diabetes treatment and the slow-release injection of encapsulated stem cells for alleviating joint pain and reversing osteoarthritis degradation. The company has achieved significant recognition, including being named one of the "50 Most Promising Start-Ups in the World." To date, Likarda has secured over $8 million in funding through private investments, grants, and contract services.

Synvect is a biotech platform that creates safe and effective ways to eliminate disease-carrying mosquitoes by stopping their breeding.

Leinco Technologies is a company that specializes in the development of high-purity monoclonal antibodies, proteins, and various reagents specifically for the diagnostic and biopharmaceutical industries. They provide a range of services, including in vitro antibody and protein production, antibody conjugations, and cell banking. Leinco Technologies focuses on augmenting the early discovery process in life science research and diagnostics, as well as contributing to the innovative development of protein therapeutics. Their expertise in optimizing and adapting products enables clients to effectively meet their research and development needs.

SeamlessHR Limited is a human resource technology software company based in Lagos, Nigeria, founded in 2013. It offers a comprehensive, cloud-based HR platform tailored for medium to large-sized organizations, facilitating the automation and optimization of HR processes from recruitment to retirement. The company's product suite includes a Recruitment Management System, HR Management System, Learning Management System, Payroll Management, Leave Management, and Performance and Competency Management tools. Additionally, SeamlessHR provides HR analytics and embedded finance solutions aimed at enhancing financial security for both employers and employees. Through its technology, SeamlessHR enables businesses to streamline various HR functions, ensuring efficient management of their workforce.

The Independent is a global news organization that delivers news, commentary, and analysis aimed at an independently-minded audience. It operates a weekly newspaper that covers a wide range of topics, including sports, business, fashion, lifestyle, real estate, entertainment, and local news. Alongside its print operations, The Independent utilizes its website and mobile apps to provide readers with current affairs and investigative reporting, ensuring comprehensive coverage of significant incidents worldwide. In addition to news articles, the publication also offers classified ads and horoscopes, catering to diverse reader interests and maintaining its position as a prominent newsbrand.

ReciBioPharm operates as a biologics company. ReciBioPharm is a division of Recipharm.

Micron Biomedical is a clinical-stage biopharmaceutical company established in 2014 and located in Atlanta, Georgia. The company focuses on developing microneedle patches specifically for vaccines, including those for influenza and polio. Its innovative microneedle technology aims to improve protective and therapeutic effects while enhancing patient compliance and simplifying the administration process. By leveraging this technology, Micron Biomedical seeks to facilitate the development of effective vaccines, addressing important public health needs.

Aptitude Medical Systems is a biotechnology research company specializing in molecular recognition technology that utilizes aptamers to address the limitations of traditional antibodies. By developing highly stable and resistant aptamers, the company offers solutions that bind with high affinity and specificity to challenging targets, even discriminating between targets that differ by a single functional group. This innovation enables a range of applications across life sciences, diagnostics, and therapeutics, facilitating the creation of advanced products tailored to meet the stringent demands of molecular recognition. Through its partnerships, Aptitude aims to advance the capabilities of molecular diagnostics and therapeutic interventions.

Tessera Therapeutics is an early-stage life sciences company focused on pioneering Gene Writing technology, which allows for the permanent modification of the human genome. This innovative approach enables scientists and clinicians to introduce therapeutic messages into the genome, offering a potential cure for diseases at their source. By building on recent advancements in gene therapy and gene editing, Tessera Therapeutics aims to address significant limitations in these areas, enhancing their applicability and effectiveness. Founded by Flagship Pioneering, the company is positioned to transform genetic medicine and improve patient care through its groundbreaking technology.

Avanti Finance operates a financial inclusion platform designed to expand access to credit and affordable financial services. The company provides an open-access digital framework that allows users and partners to create and deploy various financial products. Through this platform, Avanti Finance offers loan products and capital to third parties, enabling them to serve individuals who traditionally lack access to loans. Its approach focuses on delivering microfinance solutions via a cashless interface, thereby facilitating easier and more inclusive access to financial resources for underserved populations.

WindBorne Systems Inc., founded in 2019 and based in Stanford, California, specializes in developing and operating a network of smart weather balloons for atmospheric data collection. The company utilizes high-altitude balloons equipped with advanced sensors to gather precise measurements from various layers of the atmosphere. This data is crucial for weather forecasting, climate research, and environmental monitoring, allowing for more accurate predictions and better preparedness for severe weather events. WindBorne Systems distributes its information to both government and private weather services, contributing to efforts aimed at mitigating the impacts of climate change and improving overall understanding of climatic conditions, even in previously inaccessible regions.

VitriVax is a biotechnology startup based in Boulder, Colorado, focused on developing an innovative vaccine formulation platform. The company utilizes its proprietary atomic layering thermostable antigen and adjuvant (ALTA) technology to create vaccines that are more effective, affordable, and accessible worldwide. This technology addresses the challenges associated with vaccine stability and administration by enabling the development of thermostable, single-shot vaccines that can effectively incorporate both prime and booster doses. VitriVax's advancements in vaccine formulation aim to eliminate barriers to global vaccination, ultimately enhancing immune responses for a broad range of medical indications. The company has received significant funding, including over $5 million from various sources such as the National Institutes of Health, the National Science Foundation, and the Bill and Melinda Gates Foundation, to support its mission.

Magma Math is an e-learning math platform for K–12 classrooms that helps improve teaching practises and learning for students.

BioSurfaces is a developer of medical devices specializing in tissue engineering and personal care products. The company leverages advanced electrospinning technology to produce nanofibrous materials that facilitate controlled drug delivery and enhance healing at the implant site. By utilizing a room-temperature electrospinning process, BioSurfaces enables the integration of drug loading within each fiber, creating a reservoir for sustained drug release. This innovative approach allows for the creation of devices and coatings as thin as 10 micrometers, making it possible to treat diseases directly at the site of implantation. The company aims to provide next-generation solutions for the medical and personal care markets, focusing on improving patient outcomes through effective disease treatment and tissue regeneration.

INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health.

Dyadic International is a biotechnology company based in Jupiter, Florida, with a research and development center in the Netherlands. The company focuses on the discovery, development, manufacture, and sale of enzymes and proteins for various industries, including bioenergy, bio-based chemicals, and biopharmaceuticals. Dyadic's core technology is its patented C1 fungus, which enables the efficient production of industrial enzymes and proteins at scale. This platform allows for the discovery of novel genes and proteins and has been licensed to several third parties, including Abengoa Bioenergy, BASF, and Codexis, for non-pharmaceutical applications. Dyadic seeks to maximize the value of its technologies through licensing arrangements and collaborations, providing partners with the ability to manufacture and utilize the enzymes produced through its innovative processes.

Freya Biosciences is a clinical-stage company focused on women's health, with operations in Copenhagen and Boston. It specializes in developing microbial immunotherapies aimed at addressing significant unmet medical needs across various conditions. The company utilizes a proprietary platform to engineer and manufacture live microbes, ensuring their safety and efficacy for human use. Through this innovative approach, Freya Biosciences seeks to create new treatment options for a range of diseases, striving to make a meaningful impact in the healthcare sector.

Based in the vibrant Phoenix Metro Area and supported by a global team, Canyon GBS® is a pioneering tech company crafting impactful solutions powered by AI. With a diverse range of offerings tailored for sectors such as higher education, public sector government agencies, non-profits, and small businesses, Canyon GBS® is dedicated to enhancing operational efficiency. Our mission is to equip organizations with powerful yet accessible AI-powered technology to better serve their constituents. Through our relentless pursuit of innovation and customer-centric approach, Canyon GBS® strives to be a trusted partner in navigating today's digital landscape.

La Ruche Health provides an innovative platform that connects patients with virtual and at-home healthcare services. Utilizing health AI technology, it offers advice and facilitates the booking of medical services and lab tests through user-friendly applications on iOS, Android, and WhatsApp. The company has recognized WhatsApp as a key distribution channel, being the first to integrate generative AI into this platform to enhance conversational experiences, particularly for low-literacy communities. Additionally, La Ruche Health develops a medical record management system that enables healthcare teams to efficiently manage and exchange medical data through both web and mobile applications. This comprehensive platform allows for virtual and physical consultations, as well as access to a wellness marketplace designed to make modern health services more affordable and accessible to various communities.

PopVax is a biotechnology company that developing novel mRNA vaccines and therapeutics using computational protein design.

ApiJect Systems is a medical technology company focused on revolutionizing the delivery of injectable medications through its innovative platform for prefilled, single-dose injectors. By utilizing medical-grade plastic resin, ApiJect replaces traditional materials like glass and rubber, streamlining the manufacturing process and significantly reducing environmental impact. The ApiJect Platform enables pharmaceutical and biotech companies to efficiently produce scalable prefilled injectors, either on proprietary Blow-Fill-Seal packaging lines or through partnerships with other manufacturers. This approach not only simplifies the supply chain but also accelerates production times, transforming a multi-step process that typically takes weeks into a rapid, efficient operation. Through these advancements, ApiJect aims to make prefilled injections more affordable and accessible to patients globally.

Stellapps Technologies Private Limited is an Internet of Things (IoT) company based in Bengaluru, India, focused on enhancing the dairy supply chain. Founded in 2011, Stellapps develops a range of innovative software applications designed to optimize dairy management. Key products include SmartMoo, an automated cow-milking application aimed at reducing waste, and MooOn, a wearable device for monitoring cattle health and herd management. The company also offers smartAMCU, an automatic milk collection unit controlled via an Android IoT device, and smartCC, a cloud-based solution for managing milk chilling centers. Stellapps provides consultancy services in fodder planning, milk collection, distribution, and marketing, utilizing advanced technologies such as big data, cloud computing, and data analytics. By leveraging these technologies, Stellapps aims to improve operational efficiency and profitability for dairy farmers and cooperatives.

AN2 Therapeutics, Inc. is a biopharmaceutical company based in Menlo Park, California, founded in 2017. The company is dedicated to the research, development, and commercialization of innovative medicines aimed at addressing infectious diseases. AN2 Therapeutics is focused on developing epetraborole, a once-daily oral treatment for patients suffering from chronic non-tuberculous mycobacterial lung disease, which represents a significant unmet medical need. Additionally, the company has established a strategic partnership with Brii Biosciences to enhance its development efforts.

CanSino Biologics focuses on the R&D, manufacturing, and commercialization of vaccine products for human use. These vaccine products include pneumococcal polysaccharide and conjugate vaccines, and a DTcP-based combo, and other items. It is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine.

Imperial College London is a prestigious institution recognized globally for its strong focus on science, technology, engineering, medicine, and business. Situated in London with an extensive international network, it aims to leverage scientific research to address pressing global challenges. The university fosters an entrepreneurial spirit by providing resources that promote innovation and collaboration. Within this framework, the Imperial College Business School plays a crucial role by blending business acumen with cutting-edge technology. The school is dedicated to developing future business leaders through cutting-edge research that informs its postgraduate and Executive Education programs. Renowned for attracting top talent, it creates an environment that nurtures innovative thinking and encourages the development of practical solutions to real-world problems. Through its lifelong professional development services and a global alumni network, the institution supports its graduates in achieving successful careers across diverse industries worldwide.

Chemify is a developer of a chemical digitization platform that integrates automated synthetic hardware with a unique chemical programming language. This platform allows for the on-demand conversion of digital code into molecules, facilitating drug and materials discovery as well as chemical synthesis. Chemify's system is designed to be modular, universal, scalable, and teachable, making it suitable for various applications in chemical and material research. The software incorporates natural language processing to translate synthetic procedures and features a comprehensive ontology, which aids users in creating chemical processes while providing insights into reaction conditions and identifying potential issues. This capability enables scientists to access detailed real-time telemetry of chemical reactions, enhancing efficiency and accuracy in their work.

Radiant Biotherapeutics is an innovative company focused on developing a modular platform for multi-valent and multi-specific therapeutics. This platform aims to advance antibody engineering by producing multi-functional biologics capable of addressing challenging diseases, including cancer, autoimmune disorders, and infectious diseases. By leveraging enhanced binding power and multi-specificity, Radiant Biotherapeutics seeks to create potent therapeutics that have the potential to significantly improve treatment outcomes for patients. The company is committed to delivering transformative therapies through its cutting-edge approach to antibody technology.

Eyam Vaccines and Immunotherapeutics is a life science company focused on the research and development of vaccines aimed at combating infectious diseases. The company specializes in creating vaccines that target the spike glycoprotein protein, which generates neutralizing antibodies against the novel coronavirus. Eyam utilizes a self-amplifying vaccine platform designed to produce low-dose vaccines that offer advanced targeting capabilities for broad coverage and protection, addressing both current and emerging variants. By prioritizing the development of innovative vaccine solutions, Eyam aims to meet critical healthcare needs in the face of evolving infectious threats.

Field develops technology aimed at enhancing pharmaceutical supply chains, enabling governments and businesses to deliver healthcare more effectively in rapidly growing regions. The company's platform focuses on digitizing and modernizing supply chain processes, making them easier to use and more scalable. By partnering with communities, Field aims to strengthen and sustain these vital supply chains, ultimately improving access to healthcare for millions of people globally.

Upsolve is a nonprofit organization based in New York City that assists low-income Americans in navigating the bankruptcy process. Founded in June 2016 by Jonathan Petts and Rohan Pavuluri, Upsolve offers a free online tool that guides users through a series of questions to generate the necessary Chapter 7 bankruptcy forms. Following this, the organization's lawyers review the completed forms to ensure accuracy and compliance. By automating the bankruptcy filing process, Upsolve aims to provide essential financial guidance and support to those facing sudden financial hardships, helping them achieve a fresh start.

Propel, Inc. is a technology company based in Brooklyn, New York, founded in 2014. It specializes in developing mobile software applications aimed at improving the financial health of low-income Americans. The company's primary product, Providers, is a free app designed for EBT cardholders, enabling them to manage their government benefits, such as SNAP and rental assistance. The app also helps users save on essential expenses and earn cash, while offering features that allow them to check their balance and organize budgets around local deals. Propel's focus is on empowering its users to better navigate financial challenges and enhance their economic well-being.

Legume Technology is a producer of organic, contaminant-free, biostimulant products that are proven to increase yield. They provide services such as physicochemical improvement of pellets, compatibility testing, coating machinery, private labelling, marketing support, registration support from legume technology, pre-treatment inoculant training, application strategy and techniques. Their products like liquifix, liquifix 120, legumefix, molyfix, rootfix, extensive,and mycofix. They provide support for crops such as soya, peas, lupin, lucerne, wheat, chickpeas, clover, corn, and sunflower.

Immorna is a biotechnology company focused on developing RNA-based therapeutics and vaccines. The company employs various RNA platforms, including conventional, self-replicating, and circular RNA, to create innovative treatments. Immorna has established a comprehensive central management console for RNA synthesis, purification, and analytical testing, which facilitates both clinical and commercial development. Additionally, the company has developed advanced screening tools and a range of RNA delivery vehicles, such as polymers and lipid nanoparticles, incorporating proprietary ionizable cationic lipids. This robust infrastructure positions Immorna to contribute significantly to the field of RNA therapeutics.

Noze is a leader in digital odor perception technology, creating advanced solutions that replicate the human sense of smell. Their sophisticated digital nose utilizes a specialized sensor, developed with NASA technology, to detect and identify odors in various real-world environments. This technology collects and analyzes data through an AI engine, allowing healthcare providers to assess air quality, monitor chemical footprints, and potentially diagnose diseases based on breath-based odor biomarkers. By enabling real-time disease detection and routine health screenings with a single exhale, Noze aims to enhance human health and well-being while improving patient outcomes.

Schrödinger is a healthcare-focused software company that specializes in computational drug design, serving pharmaceutical and biotechnology research sectors. Established in 1990, it offers a powerful computational platform that aids biopharmaceutical and industrial companies, as well as academic and government institutions, in their research efforts globally. Schrödinger operates through two main segments: Software and Drug Discovery. The Software segment supplies solutions aimed at enhancing the drug discovery process across the life sciences and materials science industries. Meanwhile, the Drug Discovery segment generates revenue through a portfolio of preclinical and clinical programs, both independently and through collaborative efforts. The company is committed to advancing science and talent to support its platform and has over 400 employees, engaging with customers and collaborators in more than 70 countries.

RiseKit, Inc. is a Chicago-based company that provides software aimed at connecting entry to mid-level job candidates, particularly from underserved communities, with employment opportunities, training programs, and supportive services. Founded in 2016, RiseKit addresses employment barriers by ensuring that job seekers have access to career paths regardless of their geographic or socio-economic circumstances. The company serves a diverse clientele, including nonprofits, government agencies, and employers, helping them efficiently support job candidates and measure outcomes. By facilitating connections between untapped talent and organizations looking to hire, RiseKit not only empowers individuals to overcome obstacles to employment but also assists community partners in enhancing their capabilities through scalable software solutions.

Snipr Biome ApS is a biotechnology company based in Copenhagen, Denmark, focusing on the development of CRISPR technology for the treatment of microbial diseases. Established in 2017, the company aims to revolutionize how such diseases are addressed by leveraging the adaptive immune system to create medicines that selectively target and eliminate harmful bacteria based on their specific DNA sequences. By utilizing a novel approach that subverts elements of the endogenous bacterial CRISPR machinery, Snipr Biome provides health professionals with innovative tools for targeted microbiome engineering, enhancing the precision and effectiveness of treatments for bacterial infections.

Ethris GmbH is a biotechnology company based in Planegg, Germany, specializing in the development of innovative therapeutic solutions for diseases with unmet medical needs. The company has a focus on transcript therapeutics, particularly through its SNIM RNA platform, which offers a novel approach to treating various conditions by enabling the production of therapeutic proteins within the patient’s body. This platform presents an alternative to traditional recombinant protein and gene therapies, addressing a range of diseases, including rare and genetically predetermined conditions. Ethris also develops Magnetovax, a personalized tumor vaccine platform that utilizes magnetic fields for localized activation in tumors. The company has established strategic research collaborations with major pharmaceutical firms, enhancing its capabilities in regenerative medicine and therapeutic development. Founded in 2009, Ethris continues to advance its technologies to meet diverse medical needs.

The Alan Turing Institute is the national institute for data science. The Institute is named in honour of Alan Turing (23 June 1912 – 7 June 1954), whose pioneering work in theoretical and applied mathematics, engineering and computing are considered to be the key disciplines comprising the emerging field of data science.

Ben-Gurion University of the Negev is one of Israel’s leading research universities and among the world leaders in many fields. It has around 20,000 students and 4,000 faculty members in the Faculties of Engineering Sciences; Health Sciences; Natural Sciences; the Pinchas Sapir Faculty of Humanities and Social Sciences; the Guilford Glazer Faculty of Business and Management; the Joyce and Irving Goldman School of Medicine; the Kreitman School of Advanced Graduate Studies; and the Albert Katz International School for Desert Studies. More than 100,000 alumni play important roles in all areas of research and development, industry, health care, the economy, society, culture and education in Israel. The University has three main campuses: The Marcus Family Campus in Beer-Sheva; the research campus at Sede Boqer and the Eilat Campus, and is home to national and multi-disciplinary research institutes: the National Institute for Biotechnology in the Negev; the National Institute of Solar Energy; the Ilse Katz Institute for Nanoscale Science and Technology; the Jacob Blaustein Institutes for Desert Research; the Ben-Gurion Research Institute for the Study of Israel & Zionism, and Heksherim - The Research Institute for Jewish and Israeli Literature and Culture.

Shomvob is an integrated fintech and HR-tech platform designed to serve the emerging frontline workforce in Bangladesh. The platform focuses on creating job opportunities by assisting individuals in developing a digital professional identity and expanding their professional networks. By aligning job offerings with users' skills, qualifications, and expectations, Shomvob enhances employment prospects. Additionally, the company promotes financial inclusion through a comprehensive payroll financing product, further supporting the workforce in accessing essential financial services.

Nanite is a biotechnology company focused on non-viral gene delivery through the development of programmable polymer nanoparticles. Utilizing an artificial intelligence-driven platform, Nanite combines advanced high-throughput experimental and computational methods to create tailored delivery vehicles. These vehicles are designed to effectively transport a wide range of genetic materials with specific targeting capabilities, facilitating research in functional chemistry and enhancing the design of therapeutically relevant gene delivery systems.

Surf Bio is a preclinical biopharmaceutical company focused on developing innovative therapeutic solutions using a novel biotechnology platform. This platform centers around a next-generation surfactant designed to enhance drug effectiveness for a variety of medical conditions, including diabetes, oncology, infectious diseases, and gene therapy. By improving therapeutic applications, Surf Bio aims to provide healthcare organizations worldwide with access to new and more effective treatments for patients facing critical health issues.

Owlstone Medical Ltd is a diagnostics company based in Cambridge, United Kingdom, specializing in non-invasive breath-based diagnostic tools aimed at the early detection of diseases, including cancer and respiratory conditions. The company develops a range of innovative products, including its Breath Biopsy platform, which utilizes advanced technology to identify volatile organic compounds in breath samples. Its offerings include FAIMS technology for medical applications, Lonestar for disease biomarker detection, and ReCIVA breath samplers for in vitro analysis. Owlstone Medical's technology has significant applications in various medical fields, such as lung cancer, bowel cancer, and gastrointestinal disorders. The company is also exploring the development of a portable hand-held device that promises high sensitivity and selectivity for chemical detection, with potential applications across multiple markets, including military and industrial sectors. Owlstone Medical aims to become a leader in non-invasive diagnostics, with ongoing collaborations and trials, including contracts with the UK National Health Service for lung cancer screening initiatives.

Owlstone Medical Ltd is a diagnostics company based in Cambridge, United Kingdom, specializing in non-invasive breath-based diagnostic tools aimed at the early detection of diseases, including cancer and respiratory conditions. The company develops a range of innovative products, including its Breath Biopsy platform, which utilizes advanced technology to identify volatile organic compounds in breath samples. Its offerings include FAIMS technology for medical applications, Lonestar for disease biomarker detection, and ReCIVA breath samplers for in vitro analysis. Owlstone Medical's technology has significant applications in various medical fields, such as lung cancer, bowel cancer, and gastrointestinal disorders. The company is also exploring the development of a portable hand-held device that promises high sensitivity and selectivity for chemical detection, with potential applications across multiple markets, including military and industrial sectors. Owlstone Medical aims to become a leader in non-invasive diagnostics, with ongoing collaborations and trials, including contracts with the UK National Health Service for lung cancer screening initiatives.

Sibel Health focuses on developing advanced monitoring solutions that enhance healthcare delivery and improve patient outcomes through wireless vital signs monitoring and data integration. The company creates soft, flexible sensors capable of measuring critical parameters such as heart rate, respiratory rate, skin temperature, body position, and patient activities, including those of pregnant mothers. Sibel Health's clinical-grade digital monitoring products are portable and user-friendly, ensuring accuracy and reliability. Additionally, the company offers motion sensor-based chest and limb monitoring devices, along with a comprehensive physiological monitoring platform that incorporates advanced analytics. These innovations are designed to support medical professionals in both clinical care and research applications, particularly within the pharmaceutical and clinical research sectors.

Corner Therapeutics is a biotechnology research company focused on immunotherapy. It specializes in developing technologies that stimulate exceptional memory T cells to achieve lifelong immunity. The company utilizes a versatile dendritic cell hyperactivation platform that induces strong T-cell responses, aiming to provide robust and durable immunity against a wide range of cancers and infectious diseases. By enhancing T-cell activation, Corner Therapeutics seeks to enable healthcare providers to promote lasting immunity and optimize immune regulation.

Pula GmbH is an insurance intermediary based in Mollis, Switzerland, specializing in agricultural insurance broking services. The company focuses on providing data-driven insurance solutions for small-scale farmers across six countries in Africa. By leveraging machine learning and analyzing weather patterns and farm losses, Pula helps farmers navigate climate risks and enhance their agricultural practices. Through the use of mobile technology, Pula empowers hundreds of thousands of smallholders to protect their crops and make informed financial decisions, ultimately enabling them to invest in their farms and improve their overall income.

Ginkgo Bioworks is a biotechnology firm based in Boston, Massachusetts, that specializes in designing, engineering, and developing custom microbes and organisms for various applications. Founded in 2008, the company focuses on discovering and licensing molecules used in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. In addition to these capabilities, Ginkgo Bioworks provides probiotic bacteria that help protect against infections and creates extensive libraries of molecules. The firm operates across multiple markets, including cultured ingredients, carbon mitigation, probiotics, and natural product discovery. It has reorganized its operations into two primary segments: Cell Engineering and Biosecurity, with a significant portion of its revenue generated from biosecurity-related data analytics and services.

Antibody Solutions provides antigen design, polyclonal antibody generation, research and drug development for biopharmaceutical companies.

Detect-ION is a cutting-edge deep-tech startup that specializes in the development of sensors and systems for a variety of applications, with a focus on innovation and technological excellence.

Noze is a leader in digital odor perception technology, creating advanced solutions that replicate the human sense of smell. Their sophisticated digital nose utilizes a specialized sensor, developed with NASA technology, to detect and identify odors in various real-world environments. This technology collects and analyzes data through an AI engine, allowing healthcare providers to assess air quality, monitor chemical footprints, and potentially diagnose diseases based on breath-based odor biomarkers. By enabling real-time disease detection and routine health screenings with a single exhale, Noze aims to enhance human health and well-being while improving patient outcomes.

Phase Genomics, Inc. is a biotechnology company based in Seattle, Washington, founded in 2015. The company specializes in developing innovative technology for genome assembly and metagenome deconvolution, focusing on its ProxiMeta Hi-C platform. This platform empowers researchers in various fields, including agriculture, human health, and industrial biology, by enabling the cultivation-independent assembly of bacterial genomes. By exploiting the structure of DNA, Phase Genomics aims to provide scientists with the most complete and accurate genomes and metagenomes possible, facilitating transformative discoveries and advancements in their respective areas of study.

Food Fortification Initiative is a non-profit organization that provides the fortification of industrially milled flour and rice globally.

PhaSER Biomedical is Exploiting the 8HUM mouse, a unique mouse model with multiple utilities in drug discovery, and development.

C16 Biosciences, Inc. is a biotechnology company based in New York, established in 2017, specializing in the production of sustainable alternatives to palm oil through microbiology and fermentation processes. The firm focuses on creating innovative ingredients for food manufacturers, refiners, and consumers, aiming to decarbonize the supply chains of consumer product brands. C16 Biosciences has developed the Palmless™ platform, which features its first biodesigned ingredient, Torula oil—a premium bioactive oil known for its clinically proven benefits for skin and hair health. By leveraging biomanufacturing techniques, the company provides scalable and sustainable options, addressing the demand for environmentally friendly alternatives in the oil and fat market.

ProteinLogic’s ImmiPrint® technology impacts the emerging market for diagnostic, predictive, prognostic and other biomarker applications.

Picnic is an innovative online supermarket that focuses on delivering groceries directly to consumers' homes at competitive prices without any delivery fees. The company's platform enables users to conveniently place orders for fast-moving consumer goods, sourcing products from local suppliers such as bakers and greengrocers. Picnic utilizes electric vehicles for its delivery operations, ensuring an environmentally friendly approach to grocery shopping. By combining technology with a modern take on traditional home delivery services, Picnic aims to provide a seamless and cost-effective shopping experience for its customers.

Sail Biomedicines is a biotechnology company developing innovative medicines using circular RNA technology and programmable nanoparticles. Its platform, Endless RNA (eRNA), combined with unique, naturally-derived nanoparticles, enables the comprehensive programming of drugs, enhancing their potency and targeting capabilities. The company aims to transform patient care by leveraging artificial intelligence and advanced delivery systems to create first-in-class therapeutics.

Radiant Biotherapeutics is an innovative company focused on developing a modular platform for multi-valent and multi-specific therapeutics. This platform aims to advance antibody engineering by producing multi-functional biologics capable of addressing challenging diseases, including cancer, autoimmune disorders, and infectious diseases. By leveraging enhanced binding power and multi-specificity, Radiant Biotherapeutics seeks to create potent therapeutics that have the potential to significantly improve treatment outcomes for patients. The company is committed to delivering transformative therapies through its cutting-edge approach to antibody technology.

Brightseed, Inc. is a biotechnology company based in San Francisco, California, that specializes in the discovery of bioactive compounds in plants to enhance human health. Utilizing its advanced Forager platform, which employs artificial intelligence and machine learning algorithms, Brightseed accelerates the identification and validation of clinically beneficial molecules. This innovative approach enables the company to uncover connections between natural compounds and health outcomes, revealing the potential of bioactives that have previously remained uncharted. By integrating these discoveries back into the food supply chain, Brightseed collaborates with various companies across the consumer health continuum to develop science-backed health solutions aimed at managing chronic diseases and improving overall quality of life. Founded in 2017, Brightseed is committed to exploring the untapped resources of the plant kingdom to address pressing health challenges.

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"​) and Oral Thin Films ("OTF"​) for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

Evotec is a drug discovery partnership firm that collaborates with pharmaceutical and biotechnology companies, academic institutions, and nonprofit organizations to advance innovative therapeutic solutions. The company specializes in a range of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. Approximately 80% of its revenue comes from shared research and development services, which involve fee-for-service work and integrated drug discovery collaborations utilizing proprietary assets. The remaining 20% of sales derive from its Just-Evotec Biologics segment, which provides contract development and manufacturing organization services for biologics. Evotec's approach emphasizes collaboration with various stakeholders, including patient advocacy groups and venture capitalists, to enhance drug discovery and development processes.

Molecular Loop is a biotechnology company focused on DNA sequencing. It offers a unique approach to sequencing through its Molecular Loop targeting technology, which eliminates the need for a separate library preparation process. The company's method involves designing amplicons that tile across each target on both strands, providing sequence data with minimal additional work and cost. Molecular Loop also provides custom assays tailored to user specifications, alongside expanded and customizable carrier screening panels and SARS-CoV-2 research panels. This enables healthcare professionals and researchers to access efficient systems for production-scale targeted sequencing applications.

Ginkgo Bioworks is a biotechnology firm based in Boston, Massachusetts, that specializes in designing, engineering, and developing custom microbes and organisms for various applications. Founded in 2008, the company focuses on discovering and licensing molecules used in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. In addition to these capabilities, Ginkgo Bioworks provides probiotic bacteria that help protect against infections and creates extensive libraries of molecules. The firm operates across multiple markets, including cultured ingredients, carbon mitigation, probiotics, and natural product discovery. It has reorganized its operations into two primary segments: Cell Engineering and Biosecurity, with a significant portion of its revenue generated from biosecurity-related data analytics and services.

Naobios is a contract development and manufacturing organization (CDMO) located in Saint Herblain, France. The company specializes in bioprocess development and provides good manufacturing practice (GMP) production services for clinical batches of various biopharmaceutical products, including viral vaccines, oncolytic viruses, viral vectors, and challenge agents. Naobios assists clients in the development and optimization of processes necessary for generating live vaccine products, ensuring compliance with industry standards.

VitriVax is a biotechnology startup based in Boulder, Colorado, focused on developing an innovative vaccine formulation platform. The company utilizes its proprietary atomic layering thermostable antigen and adjuvant (ALTA) technology to create vaccines that are more effective, affordable, and accessible worldwide. This technology addresses the challenges associated with vaccine stability and administration by enabling the development of thermostable, single-shot vaccines that can effectively incorporate both prime and booster doses. VitriVax's advancements in vaccine formulation aim to eliminate barriers to global vaccination, ultimately enhancing immune responses for a broad range of medical indications. The company has received significant funding, including over $5 million from various sources such as the National Institutes of Health, the National Science Foundation, and the Bill and Melinda Gates Foundation, to support its mission.

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"​) and Oral Thin Films ("OTF"​) for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

Kyron Learning is an EdTech company focused on providing equitable access to personalized education through its online platform. The platform leverages conversational artificial intelligence technology to monitor student performance, identify challenges, and facilitate communication between students and educators. By offering interactive tools, Kyron Learning enhances the tutoring experience, enabling tutors and educational institutions to deliver high-quality, tailored educational support.

Micron Biomedical is a clinical-stage biopharmaceutical company established in 2014 and located in Atlanta, Georgia. The company focuses on developing microneedle patches specifically for vaccines, including those for influenza and polio. Its innovative microneedle technology aims to improve protective and therapeutic effects while enhancing patient compliance and simplifying the administration process. By leveraging this technology, Micron Biomedical seeks to facilitate the development of effective vaccines, addressing important public health needs.

Osmo is a company that combines artificial intelligence with olfactory science to create a platform that gives computers a sense of smell. Initially focused on the fragrance industry, Osmo develops aroma molecules for products such as perfumes, shampoos, lotions, and candles. In addition to enhancing consumer experiences, the technology has the potential to detect diseases earlier and track pandemics, ultimately aiming to improve overall health and well-being. By addressing these challenges, Osmo seeks to revolutionize how scent is integrated into everyday life and its implications for human health.

Philips, established in 1891, is a Dutch diversified technology company that focuses on improving people's health and well-being through meaningful innovation. The company operates in three segments: Diagnosis & Treatment, Connected Care, and Personal Health. Philips Healthcare, a division of Philips, is a leader in diagnostic imaging, image-guided therapy, patient monitoring, health informatics, consumer health, and home care. It offers a wide range of products such as CT scanners, MRI machines, ultrasound equipment, and more, aiming to enhance preventive care, diagnosis, and treatment. Additionally, Philips Research drives innovation across these segments, while the Philips Foundation focuses on reducing healthcare inequality through access to quality care for disadvantaged communities. The company also provides lighting solutions and consumer lifestyle products, including personal care and oral healthcare items.

BiomEdit is an innovation company focused on developing novel probiotics and microbiome-derived bioactives to enhance animal health. The company aims to tackle significant challenges in animal agriculture and food security by harnessing the potential of the microbiome. Utilizing a unique platform that incorporates high-throughput sequencing and data analytics, BiomEdit rapidly discovers and screens new probiotic species and bioactive molecules. These innovations can be engineered for improved thermostability, increased production of beneficial metabolites, and expression of immune-modulating proteins. By creating next-generation products that promote animal health without relying on antibiotics, BiomEdit addresses critical needs in livestock production and disease management.

Axmed is a business focuses on LMICs and strengthens the purchasing power of these markets to ensure the supply of cost-effective, high-quality medicines. We partner exclusively with authorized, high-quality pharmaceutical companies and certified caregivers to accelerate access to medicines.

CanSino Biologics Inc. is a biotechnology company based in Tianjin, China, focused on the research, development, manufacturing, and commercialization of vaccines. The company is actively developing a range of vaccines, including those for Ebola, meningitis, pertussis, and pneumococcal diseases, with multiple candidates currently in various phases of clinical trials. Notable products under development include the recombinant coronavirus vaccine Ad5-nCov, as well as several preclinical stage vaccines targeting adenovirus, Zika virus, meningitis, shingles, and polio. CanSino collaborates with the National Research Council of Canada to advance COVID-19 vaccine initiatives and has a co-development agreement with Precision NanoSystems to create an mRNA lipid nanoparticle vaccine against COVID-19. Founded in 2009, CanSino aims to meet the unmet medical needs in China and other emerging markets by providing high-quality vaccines at affordable prices.

Salient creates a weather intelligence platform that combines novel ocean and land-surface data with machine learning and climate expertise to provide accurate subseasonal-to-seasonal (S2S) weather forecasts 2 to 52 weeks ahead. Salient's tools sift through large datasets to identify complex climate system relationships in order to provide accurate forecasts used in agriculture, energy, finance, supply chain, and other industries. Salient utilizes scientific knowledge to assist individuals and organizations in better understanding and preparing for the increasing volatility of climate change.

STRM.BIO is a biotechnology company focused on enhancing gene therapy delivery through the use of extracellular vesicles (EVs). These natural carriers, which transport nucleic acids and proteins, offer innate targeting capabilities and can be mass-produced efficiently. By leveraging EVs, STRM.BIO aims to create a new class of therapeutics that not only introduces novel treatments but also improves the effectiveness of existing therapies. The company's approach seeks to simplify and enhance the safety of gene therapy delivery directly to patients, fulfilling the potential of this innovative medical field.

Scentian Bio is a developer of innovative biosensor devices that integrate insect biology with nanotechnology to revolutionize sensing applications. The company's technology leverages insect odorant receptors to create biosensors for commercial use in the medical and food industries. By employing machine learning, these devices can detect volatile organic compounds, such as off-notes in food and beverages, as well as identify fraud and adulterants in raw materials. Scentian Bio aims to provide users with advanced sensing solutions that harness the power of nature, making it easier to understand and respond to complex chemical signals.

AN2 Therapeutics, Inc. is a biopharmaceutical company based in Menlo Park, California, founded in 2017. The company is dedicated to the research, development, and commercialization of innovative medicines aimed at addressing infectious diseases. AN2 Therapeutics is focused on developing epetraborole, a once-daily oral treatment for patients suffering from chronic non-tuberculous mycobacterial lung disease, which represents a significant unmet medical need. Additionally, the company has established a strategic partnership with Brii Biosciences to enhance its development efforts.

GE Healthcare is a multinational healthcare company based in Chicago, Illinois, that specializes in manufacturing a diverse range of medical equipment and technologies. Founded in 1892, the company offers products and services including medical imaging, information technologies, medical diagnostics, and patient monitoring systems. GE Healthcare also supports drug discovery and biopharmaceutical manufacturing through intelligent devices and data analytics. The company aims to enhance patient care and outcomes by providing innovative healthcare solutions utilized in hospitals, clinics, research institutions, and pharmaceutical companies globally. By focusing on precision health and digitizing healthcare, GE Healthcare seeks to improve productivity and health outcomes for patients and healthcare providers alike. Additionally, the company pursues an aggressive acquisition strategy to strengthen its presence in emerging markets and expand its life sciences portfolio.

Anheuser-Busch InBev is the world's largest brewer and a leading player in the consumer goods sector. Established through the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch, the company boasts a diverse portfolio that includes six of the top ten beer brands by volume. It distributes a total of 23 brands that generate over $1 billion in retail sales. In addition to its brewing operations, Anheuser-Busch InBev manufactures and distributes both alcoholic and non-alcoholic beverages. The company has also developed a proprietary business-to-business platform, BEES, which digitizes the retail experience by connecting various steps in the distribution process to enhance consumer access. Anheuser-Busch InBev's strategic acquisitions, including the purchase of SABMiller in 2016, have further solidified its position in the global market.

Vietnam faces a disconnect between its educational priorities and the demand for skilled employees. While Vietnamese students perform well on standard academic tests, employers consistently report that students lack the skills needed to excel, as reflected in the high underemployment rate of college graduates.

Nuoc.Solutions aims to create and foster innovative, sustainable, and efficient solutions to pressing water problems in Vietnam.

The American University of Beirut (AUB), established in 1866 and formerly known as Syrian Protestant College, is a prominent educational institution located in Beirut, Lebanon. Adhering to the American liberal arts model, AUB emphasizes a teaching-centered approach to research and education. It offers over 120 academic programs across six faculties: Agricultural and Food Sciences, Arts and Sciences, Engineering and Architecture, Health Sciences, Medicine, and Business Management. The university serves approximately 8,000 students, supported by around 800 instructional faculty, with a balanced gender ratio of 50 percent male and 50 percent female. AUB fosters an environment that encourages freedom of thought and expression, aiming to cultivate graduates equipped with critical thinking skills, personal integrity, and civic responsibility. The institution is accredited by the Commission on Higher Education of the Middle States Association of Colleges and Schools in the United States, having received its initial accreditation in 2004. Instruction is primarily conducted in English, except for specific language courses.

The Lahore University of Management Sciences (LUMS) is a national university, established by sponsors belonging to the country’s leading private and public sector corporations. The goal of the sponsors is to develop an institution, which would provide rigorous academic and intellectual training and a viable alternative to education comparable to leading universities across the world.

EHA Clinics is dedicated to providing accessible, effective, and affordable healthcare services. The organization offers a comprehensive healthcare network that includes routine medical care, laboratory services, pharmacy, optometry, dental care, urgent care, and specialist consultations. EHA Clinics ensures that members have round-the-clock access to healthcare through various channels, including physical locations, telehealth virtual visits, and home care services. By leveraging technology and a skilled team, EHA Clinics aims to enhance the healthcare experience, improve patient outcomes, and offer competitive pricing for individual, family, and business members.

Bactolife is a company dedicated to addressing the global challenge of antimicrobial resistance through innovative solutions. Its proprietary Binding Protein ingredients are designed to strengthen the gut microbiome and minimize the risk of gastrointestinal infections in both humans and animals. By focusing on neutralizing harmful pathogens and their toxins while preserving beneficial microbes, Bactolife aims to enhance gut health and reduce reliance on traditional antimicrobials. The company's approach emphasizes the modulation of the gut microbiome to improve overall health outcomes, making a significant contribution to the fight against antimicrobial resistance. Through its developments, Bactolife seeks to empower individuals and communities worldwide in maintaining better health.

A-Alpha Bio, Inc. is a biotechnology company based in Seattle, Washington, established in 2017. The company specializes in synthetic biology, offering a platform known as AlphaSeq, which assists pharmaceutical companies in the development of drugs that interact with multiple targets. A-Alpha Bio provides cell-based tools for high-throughput and quantitative measurements of protein interactions, facilitating target discovery, library screening, and preclinical drug characterization. Its proprietary technology enables the mapping of protein-protein interactions at a large scale, allowing for the identification and quantification of interactions among thousands of protein pairs simultaneously. By delivering detailed maps of these interactions, A-Alpha Bio helps researchers identify potential drug targets and understand disease mechanisms, thereby streamlining the therapeutic discovery process and improving the efficiency of drug development. The company comprises a team of experts in synthetic biology, structural biology, and next-generation sequencing, focused on overcoming challenges in the drug development pipeline.

Aptitude Medical Systems is a biotechnology research company specializing in molecular recognition technology that utilizes aptamers to address the limitations of traditional antibodies. By developing highly stable and resistant aptamers, the company offers solutions that bind with high affinity and specificity to challenging targets, even discriminating between targets that differ by a single functional group. This innovation enables a range of applications across life sciences, diagnostics, and therapeutics, facilitating the creation of advanced products tailored to meet the stringent demands of molecular recognition. Through its partnerships, Aptitude aims to advance the capabilities of molecular diagnostics and therapeutic interventions.

Co-Diagnostics is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Soapbox Labs specializes in child-specific speech recognition technology that accurately captures the unique speech patterns and idiosyncrasies of children. The company's innovative voice engine is designed to support a variety of applications, including toys, gaming, robotics, augmented and virtual reality, and educational tools focused on literacy and language learning. By providing immediate and precise feedback, Soapbox Labs enhances the learning experience for children across different accents, dialects, and developmental stages. Their technology is fully compliant with COPPA and GDPR regulations, ensuring a safe environment for young users. With solutions available both online and offline, Soapbox Labs aims to foster effective voice-enabled interactions for children.

Aphea.Bio focuses on developing innovative agricultural products aimed at enhancing crop health and yields. The company specializes in creating next-generation biopesticides derived from natural microorganisms, which serve as sustainable alternatives to traditional chemical pesticides facing regulatory challenges. Additionally, Aphea.Bio produces biostimulants that promote crop growth by enhancing nutrient uptake from the soil. Utilizing proprietary technologies, the company is dedicated to discovering new biocontrol and biostimulant products that help farmers sustainably manage fungal diseases, pests, and weeds, ultimately improving crop productivity and environmental health.

Myna Mahila Foundation is a non-governmental organization that provides employment and skills to women in slum neighborhoods.

Latham BioPharm Group (LBG) specializes in providing comprehensive support for the life sciences sector, focusing on advancing programs through a range of services that include business development, program management, quality assurance, regulatory guidance, and strategic consulting. With a team averaging over 20 years of experience, many of whom have held senior positions in both private enterprises and the US government, LBG has a proven track record in biodefense, pandemic response, and product development. Over the past two decades, the firm has successfully helped clients secure more than $1 billion in government funding and over $100 million in licensing fees. Their services encompass critical business evaluations, market assessments, and assistance in obtaining funding, followed by effective program management to drive projects toward key milestones. By integrating expertise in vaccine, therapeutic, medical device, and diagnostic product development, LBG aids clients in achieving their organizational objectives efficiently and effectively.

Lectrolyst it, creating novel ways to use electricity to achieve chemical changes. From benchtop synthesis to chemical processing facilities, their technologies offer on-site, scalable solutions to match customers' industrial demands. uses electricity to create fine chemical components from waste CO2 and renewable feedstocks.

Aegis Life is a biotechnology company focused on advancing nucleic acid delivery technology, specifically through its proprietary platform known as fusogenix PLV. This technology, developed over two decades, is designed to facilitate the rapid development and commercialization of vaccines and therapeutics aimed at preventing and treating infectious diseases. Aegis Life's innovative approach supports the pharmaceutical industry in accelerating the discovery, clinical development, and manufacturing processes for vaccines and treatments, particularly in response to emerging health threats such as COVID-19.

The Council for Scientific and Industrial Research, commonly known as the CSIR, is a world-class African research and development organisation established through an Act of Parliament in 1945. The CSIR undertakes directed, multidisciplinary research and technological innovation that contributes to the improved quality of life of South Africans. The organisation plays a key role in supporting government’s programmes through directed research that is aligned with the country’s priorities, the organisation’s mandate and its science, engineering and technology competences. Key issues that the CSIR seeks to address through various interventions include: creating a vibrant economy and employment opportunities; building a capable state that is able to consistently deliver high-quality services for all South Africans; contributing to the development of economic and social infrastructure like transport, energy, water resources and ICT networks. The CSIR’s shareholder is the South African Parliament, held in proxy by the Minister of Science and Technology.

Hyperfine is a medical device company that developed Swoop, the first FDA-cleared point-of-care MRI system designed to enhance patient access to diagnostic imaging. Swoop operates at a lower magnetic field strength than traditional MRI machines, producing high-quality images quickly and efficiently. This portable system can be easily wheeled to a patient's bedside, plugged into a standard electrical outlet, and operated via an iPad, making it suitable for various clinical environments such as emergency departments and intensive care units. Hyperfine generates revenue through the sale of MRI devices and service sales, which include subscriptions for bundled devices, maintenance, and software. By providing rapid imaging capabilities at a fraction of the cost of conventional MRIs, Hyperfine aims to facilitate timely diagnoses and treatments for patients, regardless of their location or resources.

The Medicines for All Institute, operating under the auspices of the Virginia Commonwealth University School of Engineering.